Loading market data...

Bio Medica Laboratories IPO

Pharmaceutical Manufacturing - Listed on 29 May 2026

-20.0% listing gain
Issue Price (Upper)
Rs 139
Listing Price
Rs 111.2
Closing Price (NSE)
Rs 115.8
Total Subscription
2.31x

Bio Medica Laboratories IPO listing summary

Bio Medica Laboratories (Pharmaceutical Manufacturing) closed its IPO window in 2026 and listed on NSE and BSE on 29 May 2026 at an upper band issue price of Rs 139, opening at Rs 111.2 for a listing gain of -20.0% and closing day one at Rs 115.8 (-16.7% on closing basis). The IPO was subscribed 2.31x overall - QIB 15.94x, HNI/NII 1.41x, Retail 2.92x. The total issue size was Rs 52.43 Cr (Fresh Issue Rs 47.19 Cr, OFS Rs 5.24 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.

Listing day performance

Listing Gain (Open)
-20.00%
Listing Gain (Close)
-16.69%
Day Change After Listing
+4.14%
Retail Quota
35.0%

Subscription breakdown

Final (Day 3) subscription

Number of times each investor category subscribed by close of Day 3.

QIB15.94x
HNI / NII1.41x
Retail2.92x
Overall2.31x

Day-wise overall subscription

How overall subscription built up across the three-day issue window.

Day 10.72x
Day 21.06x
Day 3 (Final)2.31x

Bio Medica Laboratories IPO GMP history

Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.

DayGMP (Rs)GMP %
Day 1Rs 00.00%
Day 2Rs 5+3.60%
Day 3Rs 3+3.60%
Day 4Rs 3+3.60%
Day 5Rs 00.00%

GMP Prediction vs IPOGyani AI Prediction

Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.

GMP Prediction Range
0.0%-3.6%
IPOGyani AI Prediction
-
Actual Listing Gain
-20.0%

Issue & financials

Issue SizeRs 52.43 Cr
Fresh IssueRs 47.19 Cr
OFSRs 5.24 Cr
IPO PE13.03
Peer / Sector PE-
PE vs Sector Ratio-
Latest EBITDA (Cr)39.83
Debt / Equity1.02

Market context at listing

How the broader market moved around the Bio Medica Laboratories IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.

Nifty 3D Return+0.32%
Nifty 1W Return+0.32%
Nifty 1M Return-1.88%
Nifty during IPO window+1.48%

Bio Medica Laboratories IPO - FAQs

What was the listing gain of Bio Medica Laboratories IPO?

Bio Medica Laboratories IPO listed at -20.0% versus the upper issue price of Rs 139 on 29 May 2026.

How many times was Bio Medica Laboratories IPO subscribed?

Bio Medica Laboratories IPO was subscribed 2.31x overall. QIB portion was subscribed 15.94x, HNI / NII 1.41x and Retail 2.92x.

What was the IPO GMP for Bio Medica Laboratories?

IPO GMP started at Rs 0 on Day 1 and moved to Rs 0 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.

Other IPOs listed in 2026

Browse listed IPOs by year